MONOSTOTIC OSTEOFIBROUS DYSPLASIA OF THE TIBIA

  • Maimoona Siddique Nuclear Medicine Department, Shaukat Khanum Memorial Cancer Hospital & Research Centre, Lahore
  • Humayun Bashir Nuclear Medicine Department, Shaukat Khanum Memorial Cancer Hospital & Research Centre, Lahore
  • Imran K Niazi Radiology Department, Shaukat Khanum Memorial Cancer Hospital & Research Centre, Lahore
  • Ahsan Shamim Surgical oncology department, Shaukat Khanum Memorial Cancer Hospital & Research Centre, Lahore
DOI: https://doi.org/10.37029/jcas.v2i1.57

Abstract

An 11-year-old boy presented with painful swelling of leg following fracture of tibia. Osteo brous dysplasia (OFD) is an uncommon, benign, non-hereditary bone disorder in which brous tissue develops in place of normal bone that affects the young adults in their rst and second decade of life. Tc-99m MDP whole-body bone scintigraphy revealed increased tracer uptake in dense proximal tibia. On single-photon remission computed tomography-computed tomography (SPECT-CT), radiological features of cortical-based lesion superimposed on abnormal tracer uptake con rmed it to be a monostotic OFD. This case emphasises the role of SPECT-CT and magnetic resonance imaging in detecting osteo brous dysplasia and differentiating it from other benign bone conditions. 

Key words: Bone scintigraphy, magnetic resonance imaging, monostotic osteo brous dysplasia, single-photon emission computed tomography computed tomography, tibia

References

McCaffrey M, Letts M, Carpenter B, et al. Osteo brous dysplasia: A review of the literature and presentation of an additional 3 cases. Am J Orthop 2003;32:479-86.

Gleason BC, Liegl-Atzwanger B, Kozakewich HP, et al. Osteo fibrous dysplasia and adamantinoma in children and adolescents: A clinicopathologic reappraisal. Am J Surg Pathol 2008;32:363-76.

Frangenheim P. Congenital ostitis brosa as the cause an intrauterine fracture of the lower leg. Arch Klin Chir 1921;117:22 9.

Campanacci M. Osteo brous dysplasia of long bones a new clinical entity. Ital J Orthop Traumatol 1976;2:221-37.

Feller L, Wood NH, Khammissa RA, et al. The nature of fibrous dysplasia. Head Face Med 2009;5:22.

Davidson D, Chapurlat G. Osteofibrous Dysplasia. Available from: http://www emedicine.medscape.com/ article/1256595-overview. [Last accessed on 2016 Mar 11].

Campanacci M, Laus M. Osteo brous dysplasia of the tibia and fibula. J Bone Joint Surg Am 1981;63:367-75.

Ishida T, Iijima T, Kikuchi F, et al. A clinicopathological and immunohistochemical study of osteo brous dysplasia, differentiated adamantinoma, and adamantinoma of long bones. Skeletal Radiol 1992;21:493-502.

Zamzam MM. Congenital osteo brous dysplasia of the tibia, associated with pseudoarthrosis of the ipsilateral bula. Saudi Med J 2008;29:1507-9.

Lee RS, Weitzel S, Eastwood DM, et al. Osteo brous dysplasia of the tibia. Is there a need for a radical surgical approach? J Bone Joint Surg 2006;88:658-64.

Bosse A, Niesert W, Wuisman P, et al. Fibrous dysplasia versus osteofibrous dysplasia. Morphological, differential diagnostic and clinical aspects. Experiences from the Westfalen bone tumor registry. Z Orthop Ihre Grenzgeb 1993;131:42-50.

DiCaprio MR, Enneking WF. Fibrous dysplasia. Pathophysiology, evaluation, and treatment. J Bone Joint Surg Am 2005;87:1848-64.

Wang K, Allen L, Fung E, et al. Bone scintigraphy in common tumors with osteolytic components. Clin Nucl Med 2005;30:655-71.

Tuncel M, Kiratli PO, Gedikoglu G. SPECT CT imaging of poliostotic brous dysplasia. Rev Esp Ned Nucl Imagen Mol 2012;31:47-8.

Nakahara T, Fujii H, Hashimoto J, et al. Use of bone SPECT in the evaluation of brous dysplasia of the skull. Clin Nucl Med 2004;29:554-9.

Published
2016-05-05
How to Cite
1.
Siddique M, Bashir H, Niazi IK, Shamim A. MONOSTOTIC OSTEOFIBROUS DYSPLASIA OF THE TIBIA. J Cancer Allied Spec [Internet]. 2016May5 [cited 2024Apr.26];2(1). Available from: https://journals.sfu.ca/jcas/index.php/jcas/article/view/57
Issue
Vol 2 No 1 (2016): Journal of Cancer & Allied Specialties
Section
Clinical Case Report
Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.

Authors retain copyright and grant the Journal of Cancer & Allied Specialties (JCAS) right-of-first publication. In addition, the work will be simultaneously licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International license. This license allows others to share the work in whole or part (for non-commercial purpose), with an acknowledgement of the work’s authorship and initial publication in JCAS.

Furthermore, authors are free to enter into separate contractual arrangements for the non-exclusive distribution of the journal’s published version of the work, with an acknowledgement of its initial publication in this journal.

Authors are permitted and encouraged to share their work online or in medical or scientific conferences prior to or during submission process.

Crossref
Scopus
Google Scholar
Europe PMC